Upcoming special issue
Second lung malignancy and Richter syndrome in chronic lymphocytic leukemia: case report and literature review
Published on: 29 September 2017
Original research article
Published on: 9 September 2017
Original research article
Published on: 21 August 2017
The official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP)
Aims and scope
Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research.
The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.
Given the journal’s interdisciplinary character, the target readership is wider than respiratory medicine, embracing numerous related disciplines (allergology, immunology, internal medicine, geriatrics, infectious diseases, intensive care, etc) and health professionals.
Discounts for BioMed Central members
BioMed Central has a total of 522 Members across 56 countries, including 14 Italian institutions. Members can benefit from discounted or waived article processing charges (APCs) when publishing in Multidisciplinary Respiratory Medicine. Click here to find out more about our member institutions.
Sign up to receive article alerts
Multidisciplinary Respiratory Medicine is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.
Featured review: Recent advances in capsule-based dry powder inhaler technology
Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in the lungs. Among the available delivery options, the dry powder inhaler (DPI) is the preferred device for the treatment of an increasingly diverse range of diseases. This article reviews recent advances in capsule-based DPI technology and the introduction of the ‘disposable’ DPI device.
Featured article: Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice
The intratracheal instillation of bleomycin in mice induces early damage to alveolar epithelial cells and development of inflammation followed by fibrotic tissue changes. Histopathology is the gold standard for assessing lung fibrosis in rodents, however it precludes repeated and longitudinal measurements of disease progression. This study investigates the use of the Micro-CT technique to allow the evaluation of disease onset and progression at different time-points in the mouse bleomycin model of lung fibrosis.